Literature DB >> 6438534

Serine- and threonine-specific protein kinase activities of purified gag-mil and gag-raf proteins.

K Moelling, B Heimann, P Beimling, U R Rapp, T Sander.   

Abstract

Retroviruses carry cell-derived oncogenes (v-onc) that have the potential to transform cells in culture and induce tumours in vivo. One of the few carcinoma-inducing viruses is the acutely transforming retrovirus MH2, which carries the putative oncogene v-mil and the known oncogene v-myc. Recently, a high degree of homology was discovered between v-mil and v-raf, the transforming gene of the murine retrovirus 3611 murine sarcoma virus (MSV), whereas homology to v-src is low. Both viruses express their oncogenes as the gag-fusion polyproteins p100gag-mil and p75gag-raf (of respective relative molecular mass (Mr) 100,000 and 75,000), while the myc oncogene of MH2 is expressed by means of a subgenomic messenger RNA. We have recently demonstrated that p100gag-mil is not a nuclear protein. Here we report that purified p100gag-mil and p75gag-raf exhibit protein kinase activities in vitro which, in contrast to the src-related p130gag-fps of Fujinami sarcoma virus (FSV) and all other characterized oncogene-encoded protein kinases, phosphorylate serine and threonine but not tyrosine. Both types of protein kinases phosphorylate lipids in vitro.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438534     DOI: 10.1038/312558a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  71 in total

1.  The Bcr kinase downregulates Ras signaling by phosphorylating AF-6 and binding to its PDZ domain.

Authors:  G Radziwill; R A Erdmann; U Margelisch; K Moelling
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

2.  Development of a highly efficient expression cDNA cloning system: application to oncogene isolation.

Authors:  T Miki; T P Fleming; M Crescenzi; C J Molloy; S B Blam; S H Reynolds; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

3.  Two nuclear oncogenic proteins, P135gag-myb-ets and p61/63myc, cooperate to induce transformation of chicken neuroretina cells.

Authors:  P Amouyel; V Laudet; P Martin; R P Li; B Quatannens; D Stéhelin; S Saule
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

4.  Transcription of a quail gene expressed in embryonic retinal cells is shut off sharply at hatching.

Authors:  M Guermah; P Crisanti; D Laugier; P Dezelee; L Bidou; B Pessac; G Calothy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

5.  Phosphatidylinositol kinase activity in virus-transformed and nontransformed cells.

Authors:  S Sugano; H Hanafusa
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

Review 6.  Tumor adaptation and resistance to RAF inhibitors.

Authors:  Piro Lito; Neal Rosen; David B Solit
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 7.  Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond.

Authors:  Matthew Holderfield; Marian M Deuker; Frank McCormick; Martin McMahon
Journal:  Nat Rev Cancer       Date:  2014-07       Impact factor: 60.716

8.  Enzymatic characteristics of the c-Raf-1 protein kinase.

Authors:  T Force; J V Bonventre; G Heidecker; U Rapp; J Avruch; J M Kyriakis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

Review 9.  Vemurafenib: the first drug approved for BRAF-mutant cancer.

Authors:  Gideon Bollag; James Tsai; Jiazhong Zhang; Chao Zhang; Prabha Ibrahim; Keith Nolop; Peter Hirth
Journal:  Nat Rev Drug Discov       Date:  2012-10-12       Impact factor: 84.694

10.  Actively transcribed genes in the raf oncogene group, located on the X chromosome in mouse and human.

Authors:  K Huebner; A ar-Rushdi; C A Griffin; M Isobe; C Kozak; B S Emanuel; L Nagarajan; J L Cleveland; T I Bonner; M D Goldsborough
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.